Monashee Investment Management LLC Insmed Inc Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$22.46 - $29.47 $1.95 Million - $2.56 Million	-87,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$24.17 - $36.01 $2.1 Million - $3.13 Million	87,000 New	87,000 $2.48 Million
Q4 2017 Feb 09, 2018	SELL	$26.43 - $31.78 $6.45 Million - $7.75 Million	-244,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$11.61 - $31.21 $2.83 Million - $7.62 Million	244,000	244,000 $7.62 Million

484

187M

2.15M

3.22M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.7B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.